A company that specializes in using cannabis as a form of medication has come up with a revolutionary pain patch that can be used to treat diabetic nerve pain and fibromyalgia symptoms.
This could change the way that cannabis looks in the medical world forever.
The new drugs are designed to be administered as transdermal patches, which are basically sticky patches that stick to the skin and release certain chemicals over time to help combat neurological nerve pain associated with diabetes and fibromyalgia. The use of this medium means that a controlled dose of the medication can be administered on a daily basis, with no negative side effects discovered so far.
“Promote healing to an injured area of the body.
An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. Is that the patch provides a controlled release of the medication into the patient, usually through a porous membrane covering a reservoir of medication or through the heat of the body that melts the thin layers of medication embedded in the glue that will contain the High potency cannabinoid extract (CBD) that slowly enters the bloodstream and then penetrates the patient’s central nervous system delivering the relief of the pain sought.
CBD is the second most important cannabinoid contained in cannabis, the main one being THC.
The CBD has incredible analgesic and anti-inflammatory properties and comes from a completely natural source with very few side effects, including the hallucinogenic effects commonly associated with THC.
Raymond C Dabney, CEO of Cannabis Science, said:
“The development of these two new medicinal pharmaceutical applications are just the tip of the iceberg for what we see as the future of Cannabis Science.
While we strive to increase our earth growth capacity and facilities to produce our own product to supply our scientists with proprietary materials to make these formulations, we are also busy investigating more potential needs for cannabis related medical applications and development Of the methods for the delivery of these Medicines “.
Fibromyalgia is thought to affect up to 10% of us, with a large number of undiagnosed patients. Nerve Neuropathy Diabetic pain affects a large number of people around the world, and this new treatment will be a big step in the right direction to limit certain symptoms, and maybe even cure these diseases forever.
Mr. Dabney concludes:
“As more states across the country legislate for the legalization of cannabis and cannabis-derived drugs, here at Cannabis Science they focus on the development of pharmaceutical formulations and applications to meet the huge and growing demand expected in the coming years.”